MARKET

RXST

RXST

Rxsight, Inc.
NASDAQ
7.56
+0.23
+3.14%
Opening 10:48 03/16 EDT
OPEN
7.45
PREV CLOSE
7.33
HIGH
7.62
LOW
7.42
VOLUME
50.77K
TURNOVER
--
52 WEEK HIGH
27.13
52 WEEK LOW
6.32
MARKET CAP
311.97M
P/E (TTM)
-7.9303
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RXST last week (0309-0313)?
Weekly Report · 5h ago
Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX) and RxSight (RXST)
TipRanks · 6d ago
RxSight Price Target Cut to $9.00/Share From $10.00 by Stifel
Dow Jones · 03/09 12:56
RxSight Is Maintained at Hold by Stifel
Dow Jones · 03/09 12:56
Stifel Maintains Hold on RxSight, Lowers Price Target to $9
Benzinga · 03/09 12:46
Weekly Report: what happened at RXST last week (0302-0306)?
Weekly Report · 03/09 09:03
RxSight Earnings Call: Strong Core, Cautious Outlook
TipRanks · 03/09 00:09
Analysts Have Conflicting Sentiments on These Healthcare Companies: Silence Therapeutics (SLN), RxSight (RXST) and Compass Therapeutics (CMPX)
TipRanks · 03/06 14:40
More
About RXST
RxSight, Inc. is a commercial-stage medical technology company dedicated to providing customized vision to patients following cataract surgery. The Company's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.

Webull offers Rxsight Inc stock information, including NASDAQ: RXST real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RXST stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RXST stock methods without spending real money on the virtual paper trading platform.